Claymount Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Claymount Group - overview
Established
1984
Location
-, -, Netherlands
Primary Industry
Medical Devices & Equipment
About
Claymount Group is a specialist in designing and manufacturing high voltage connections, serving various industries including medical, industrial, and scientific X-ray applications with a focus on reliability and innovative engineering. Claymount Group was founded in 1984 in the Netherlands. The company specializes in high voltage connections tailored for medical and industrial applications, without known major pivots in its operations. The firm's recent history includes two significant deals, with the most recent transaction occurring on October 1, 2010, when GIMV sold its 42.
5% stake to QSolid B. V. Claymount Group's core offerings include specialized high voltage cables, connectors, and receptacles designed for demanding applications in healthcare, security systems, and industrial sectors. Their products are recognized for quality and reliability, facilitating integration into critical systems such as X-ray machines, with a customer base spanning North America, Europe, and Asia.
For the year 2022, Claymount Group reported a revenue of USD 65. 16 mn and an EBITDA of USD 12. 00 mn, driven primarily by direct sales to OEMs and distributors for their high voltage connections. Looking ahead, Claymount Group plans to expand its product line, focusing on the development of advanced high voltage connections aimed at new healthcare technologies.
Geographically, they are targeting expansion into Asian markets by 2025, aiming to establish partnerships with local distributors. Recent funding from their last deal in 2010 will be strategically utilized to support these growth initiatives and further enhance product offerings.
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment
Website
www.claymount.com
Verticals
HealthTech, Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Claymount Group - financials
| Fiscal Year Ended | Sep 29, 2017 | Sep 28, 2018 | Sep 27, 2019 | Oct 02, 2020 | Oct 01, 2021 | Sep 30, 2022 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 33,188,310 | - | 47,632,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - |
| EBITDA (USD) | 8,169,632 | 8,504,490 | 8,422,000 | - | - | - |
| Operating Income (USD) | 6,625,869 | 6,616,120 | 6,670,000 | - | - | - |
| Operating Margin | 20.0% | - | 14.0% | - | - | - |
| % EBITDA Margin | 24.6% | - | 17.7% | - | - | - |
| NET Income (USD) | 6,970,728 | 5,408,553 | 5,097,000 | - | - | - |
| % Net Margin | 21.0% | - | 10.7% | - | - | - |
Claymount Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Varian Medical Systems, Inc. | - | ||||||||
| Trade Sale | Completed | Claymount Group | - | ||||||||
| Buyout | Completed | Claymount Group | - |
Displaying 1 - 3 of 3

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.